This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Hanover Bancorp (HNVR) Announces New Share Repurchase Plan
by Zacks Equity Research
Hanover Bancorp (HNVR) announces a new share repurchase program. This, along with steady payouts, is set to enhance shareholder value.
Robinhood Markets (HOOD) Buys Shares From Emergent Fidelity
by Zacks Equity Research
Robinhood Markets (HOOD) purchases 55,273,469 shares originally acquired by Emergent Fidelity for $605.6 million, underlining management's confidence in their business.
Pathward Financial (CASH) Announces New Share Repurchase Plan
by Zacks Equity Research
Pathward Financial (CASH) introduces a new share repurchase program, authorizing the repurchase of 7 million shares. This is expected to boost shareholders' confidence in the stock.
State Street (STT) Rides on Expansion Efforts Amid Expense Woes
by Zacks Equity Research
Higher rates, inorganic growth strategy and global reach are likely to keep supporting State Street (STT). However, rising expenses and substantial exposure to fee income are major near-term woes.
Best Momentum Stock to Buy for July 28th
by Zacks Equity Research
GE, CASH and MFIN made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 28, 2023.
Pathward (CASH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Pathward (CASH) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Pathward Financial (CASH) Beats Q3 Earnings Estimates
by Zacks Equity Research
Pathward (CASH) delivered earnings and revenue surprises of 23.94% and 1.43%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate The First of Long Island (FLIC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
The First of Long Island (FLIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pathward Financial (CASH) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Pathward (CASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pathward Financial, Inc. (CASH) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Pathward (CASH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The Zacks Analyst Blog Highlights Pathward Financial, Coastal Financial and CB Financial
by Zacks Equity Research
Pathward Financial, Coastal Financial and CB Financial are included in this Analyst Blog.
3 Top Bank Stocks to Gain as Powell Stays Hawkish
by Tirthankar Chakraborty
Powell's hawkish testimony likely to lift bank stocks. Investors, thus, should bet on stocks like Pathward Financial (CASH), Coastal Financial (CCB) & CB Financial Services (CBFV) for now.
Pathward (CASH) Launches a Line of Credit for Underserved
by Zacks Equity Research
Pathward (CASH) launches the Pathward Line of Credit in partnership with Propel to provide credit solutions to the underserved population.
Invesco (IVZ) Aided by Robust AUM Amid a Fall in Revenues
by Zacks Equity Research
Lower expenses, robust AUM balance, diverse product offerings and global presence are likely to keep supporting Invesco (IVZ). Yet, a challenging operating environment will hamper top-line growth.
Morgan Stanley's (MS) Inorganic Expansion Aids Amid High Costs
by Zacks Equity Research
Strategic business expansion efforts to focus on WM & IM segments are likely to support Morgan Stanley (MS). Yet, rising expenses and uncertain performance of capital markets are headwinds.
Associated Banc-Corp (ASB) Rides on Organic Growth Amid Cost Woes
by Zacks Equity Research
Strategic business expansion initiatives, decent loan demand and higher rates will continue to aid Associated Banc-Corp's (ASB) financials amid huge commercial loan exposure and mounting expenses.
Moody's (MCO) Aided by Strategic Buyouts Amid Rising Costs
by Zacks Equity Research
Focus on diversifying revenues and inorganic expansion initiatives are likely to support Moody's (MCO) amid stiff competition and mounting operating expenses.
Cullen/Frost (CFR) Aided by High Interest Rates Amid Cost Woes
by Zacks Equity Research
Cullen/Frost (CFR) continues to benefit from higher loans, rising interests and franchise expansion moves. However, deteriorating credit quality and an undiversified loan portfolio are concerning.
Fifth Third (FITB) Rides on Organic Growth Amid Cost Woes
by Zacks Equity Research
Diversified revenue sources, along with a rise in loans and deposits, are likely to support Fifth Third (FITB). However, mounting expenses and major exposure to commercial loans are headwinds.
5 Reasons Why Trustmark Corporation (TRMK) Stock Is a Must Buy
by Zacks Equity Research
A solid loan and deposit balance, higher rates and a focus on improving fee income are likely to continue to support Trustmark Corporation's (TRMK) financials going forward.
Northern Trust (NTRS) Rolls Out A-Suite for Asset Owners
by Zacks Equity Research
Northern Trust's (NTRS) A-Suite will offer content, research and peer networking opportunities to asset owners and allocators.
Citigroup's (C) Streamlining Effort Aids Amid Cost Woes
by Zacks Equity Research
Citigroup's (C) efforts to divest its consumer banking business internationally and diversifying revenue sources are likely to support financials. However, high costs and legal hassles are concerning.
BOK Financial (BOKF) Forays Into San Antonio for Texas Expansion
by Zacks Equity Research
BOK Financial's (BOKF) debut in San Antonio underlines its efforts to expand in the Texas region. The company will benefit from the dynamic and fast-growing market.
T. Rowe Price's (TROW) Revenues & AUM Aid Amid Rising Expenses
by Zacks Equity Research
Rising revenues backed by AUM growth and inorganic expansion moves are likely to support T. Rowe Price (TROW). Yet, elevated expenses and overdependence on investment advisory fees are concerns.
Synovus' (SNV) Balance Sheet Profile Aids Amid High Costs
by Zacks Equity Research
Strong balance sheet growth and a rise in revenues are likely to keep supporting Synovus (SNV). However, a rise in expenses and a concentrated loan portfolio are the major headwinds.